Cargando…

SARS-CoV-2 infection in pregnant female mouse featured as delayed anti-viral response

Detalles Bibliográficos
Autores principales:	Liu, Lu, Zhu, GuoHua, Du, MeiRong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier/North-Holland Biomedical Press 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029062/ http://dx.doi.org/10.1016/j.jri.2023.103890

Ejemplares similares

Delayed Antiviral Immune Responses in Severe Acute Respiratory Syndrome Coronavirus Infected Pregnant Mice
por: Zhu, Guohua, et al.
Publicado: (2022)

Acute necrotizing encephalopathy due to SARS-CoV-2 in a pregnant female
por: Breit, Hannah, et al.
Publicado: (2021)

SARS-CoV-2 Seropositivity and HIV Viral Load Among Mozambican Pregnant Women
por: González, Raquel, et al.
Publicado: (2023)

Viral anti‐inflammatory serpin reduces immuno‐coagulopathic pathology in SARS‐CoV‐2 mouse models of infection
por: Zhang, Liqiang, et al.
Publicado: (2023)

Dysregulation of Innate and Adaptive Immune Responses in Asymptomatic SARS-CoV-2 Infection with Delayed Viral Clearance
por: Cao, Shanshan, et al.
Publicado: (2022)

SARS-CoV-2: From the pathogenesis to potential anti-viral treatments
por: Zarandi, Peyman Kheirandish, et al.
Publicado: (2021)

Biosynthetic proteins targeting the SARS-CoV-2 spike as anti-virals
por: Thébault, Stéphanie, et al.
Publicado: (2022)

Modeling the viral dynamics of SARS-CoV-2 infection
por: Wang, Sunpeng, et al.
Publicado: (2020)

Highlight of potential impact of new viral genotypes of SARS-CoV-2 on vaccines and anti-viral therapeutics
por: Ghorbani, Abozar, et al.
Publicado: (2022)

Viral Transmission and Clinical Features in Asymptomatic Carriers of SARS-CoV-2 in Wuhan, China
por: Tan, Fen, et al.
Publicado: (2020)

Emerging neurotropic features of SARS-CoV-2
por: Zhan, Wen-Rong, et al.
Publicado: (2021)

Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral Variants
por: Chaqroun, Ahlam, et al.
Publicado: (2021)

Anti-N SARS-CoV-2 assays for evaluation of natural viral infection
por: Gaeta, Aurelia, et al.
Publicado: (2023)

Oral favipiravir for patients with delayed SARS-CoV-2 viral RNA clearance: a case series
por: Fu, Dian, et al.
Publicado: (2020)

A Nomogram for Predicting Delayed Viral Shedding in Non-Severe SARS-CoV-2 Omicron Infection
por: Yu, Tianyu, et al.
Publicado: (2023)

Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2
por: Israelow, Benjamin, et al.
Publicado: (2021)

Diltiazem inhibits SARS-CoV-2 cell attachment and internalization and decreases the viral infection in mouse lung
por: Wang, Xinxin, et al.
Publicado: (2022)

Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
por: Runfeng, Li, et al.
Publicado: (2020)

Chitosan and its derivatives as polymeric anti-viral therapeutics and potential anti-SARS-CoV-2 nanomedicine
por: Tan, Rebecca Shu Ling, et al.
Publicado: (2022)

Clinical Features and Duration of Viral Shedding in Individuals With SARS-CoV-2 Omicron Variant Infection
por: Jang, Young R, et al.
Publicado: (2022)

Case series of SARS‐COV‐2 infection in pregnant African women: focus on biological features
por: Minkobame, Ulysse, et al.
Publicado: (2021)

A comparative analysis for anti-viral drugs: Their efficiency against SARS-CoV-2
por: Kivrak, Arif, et al.
Publicado: (2021)

New Analogues of Uridine as Possible Anti-Viral Agents Specific to SARS-CoV-2
por: Maslova, A. A., et al.
Publicado: (2022)

Obesity Challenge Drives Distinct Maternal Immune Response Changes in Normal Pregnant and Abortion-Prone Mouse Models
por: Li, Yanhong, et al.
Publicado: (2021)

SARS-CoV-2 viral RNA levels are not 'viral load'
por: Michalakis, Yannis, et al.
Publicado: (2021)

Case of a pregnant woman with probable prolonged SARS-CoV-2 viral shedding 221 days after diagnosis
por: Akine, Dai, et al.
Publicado: (2022)

SARS-CoV-2 Infection in Pregnant Women and Their Newborns
por: Etti, Melanie, et al.
Publicado: (2020)

The microbiota of pregnant women with SARS-CoV-2 and their infants
por: Leftwich, Heidi K., et al.
Publicado: (2023)

Laboratory characteristics of pregnant compared to non-pregnant women infected with SARS-CoV-2
por: Mohr-Sasson, Aya, et al.
Publicado: (2020)

Electrostatic features for nucleocapsid proteins of SARS-CoV and SARS-CoV-2
por: Guo, Wenhan, et al.
Publicado: (2021)

COMPARATIVE BURDEN OF DELAYED MYOCARDITIS AFTER SARS COV2 AND OTHER ACUTE RESPIRATORY VIRAL INFECTION
por: Begur, Maedha, et al.
Publicado: (2023)

Waiting for the truth: is reluctance in accepting an early origin hypothesis for SARS-CoV-2 delaying our understanding of viral emergence?
por: Canuti, Marta, et al.
Publicado: (2022)

P-87 HIGH PREVALENCE OF SARS-COV-2 ANTIBODIES IN PREGNANT WOMEN INFECTED WITH VIRAL HEPATITIS IN BRAZIL
por: Calheiros Santos, Alanna, et al.
Publicado: (2021)

SARS-CoV-2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with PCOS and COVID-19
por: Huffman, Alexandra M., et al.
Publicado: (2021)

SARS-CoV-2 Viral Sepsis with Meningoencephalitis
por: Dharsandiya, Mitkumar, et al.
Publicado: (2020)

SARS-CoV-2 Mutations and their Viral Variants
por: Cosar, Begum, et al.
Publicado: (2022)

Therapeutic Strategies in the Development of Anti-viral Drugs and Vaccines Against SARS-CoV-2 Infection
por: Bhatti, Jasvinder Singh, et al.
Publicado: (2020)

A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions
por: Neerukonda, Sabari Nath, et al.
Publicado: (2020)

Gramicidin S and melittin: potential anti-viral therapeutic peptides to treat SARS-CoV-2 infection
por: Enayathullah, Mohammed Ghalib, et al.
Publicado: (2022)

Repositioning of anti-dengue compounds against SARS-CoV-2 as viral polyprotein processing inhibitor
por: Bajrai, Leena H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8rb2tjvpres4if3heo8oiab5k6